FDA Approval Activities for this Drug
Imitrex (sumatriptan succinate) Injection, Glaxo Wellcome NDA 20-626/S-006 Imitrex (sumatriptan) tablets, GlaxoSmithKline | Imitrex (sumatriptan) nasal spray, GlaxoSmithKline, Patient Population Altered | Sumatriptan Succinate Tablets, Cobalt Pharma, Tentative Approval | Sumatriptan Succinate Tablets (25 & 50mg), Ranbaxy, Tentative Approval | Sumatriptan Succinate Tablets (100mg), Ranbaxy, Tentative Approval | Imitrex (sumatriptan) Injection, GlaxoSmithKline, New Dosage Regimen | Sumatriptan Succinate Tablets, Mylan Pharma, Tentative Approval | Sumatriptan Succinate Injection, Spectrum Pharma, Tentative Approval | Sumatriptan Succinate Tablets, Teva Pharma, Tentative Approval | Sumatriptan Succinate Tablets, Sandoz, Inc., Tentative Approval | Sumatriptan Succinate Tablets, Genpharm, Tentative Approval | Sumatriptan Succinate Injection, Sicor Pharma, Tentative Approval | Sumatriptan Succinate Tablets, Roxane Labs, Tentative Approval | Sumatriptan Succinate Tablets, Dr. Reddy’s Labs, Tentative Approval | Sumatriptan Succinate Tablets, Watson Labs, Tentative Approval | Sumatriptan Succinate Tablets, Aurobindo Pharma, Tentative Approval | Treximet (sumatriptan, naproxen sodium) Tablets, Prozen Inc., Approval | Sumatriptan Succinate Injection, Teva Parenteral Medicines, Tentative Approval | Sumatriptan Succinate Injection, Wockhardt Ltd., Tentative Approval